GB9828845D0 - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases - Google Patents

Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Info

Publication number
GB9828845D0
GB9828845D0 GBGB9828845.9A GB9828845A GB9828845D0 GB 9828845 D0 GB9828845 D0 GB 9828845D0 GB 9828845 A GB9828845 A GB 9828845A GB 9828845 D0 GB9828845 D0 GB 9828845D0
Authority
GB
United Kingdom
Prior art keywords
biarylbutyric
substituted
treatment
acid derivatives
respiratory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828845.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GBGB9828845.9A priority Critical patent/GB9828845D0/en
Publication of GB9828845D0 publication Critical patent/GB9828845D0/en
Priority to EP99963582A priority patent/EP1140768A1/en
Priority to CA002356053A priority patent/CA2356053A1/en
Priority to PCT/EP1999/010110 priority patent/WO2000040539A1/en
Priority to TR2001/01970T priority patent/TR200101970T2/en
Priority to KR1020017008314A priority patent/KR20010101325A/en
Priority to IL14359499A priority patent/IL143594A0/en
Priority to CN99816404A priority patent/CN1337932A/en
Priority to JP2000592250A priority patent/JP2002534404A/en
Priority to BR9916669-0A priority patent/BR9916669A/en
Priority to US09/869,668 priority patent/US6900194B1/en
Priority to AU19825/00A priority patent/AU1982500A/en
Priority to PE1999001333A priority patent/PE20001339A1/en
Priority to ARP990106795A priority patent/AR035472A1/en
Priority to CO99081622A priority patent/CO5261506A1/en
Priority to UY25888A priority patent/UY25888A1/en
Priority to GT199900229A priority patent/GT199900229A/en
Priority to ZA200104651A priority patent/ZA200104651B/en
Priority to HK02105193.2A priority patent/HK1043981A1/en
Ceased legal-status Critical Current

Links

GBGB9828845.9A 1998-12-30 1998-12-30 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases Ceased GB9828845D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9828845.9A GB9828845D0 (en) 1998-12-30 1998-12-30 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU19825/00A AU1982500A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
JP2000592250A JP2002534404A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric acid and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
US09/869,668 US6900194B1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
PCT/EP1999/010110 WO2000040539A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
TR2001/01970T TR200101970T2 (en) 1998-12-30 1999-12-20 The use of substituted 4-biarylbutyric and 5-biarylpentanoic acid t revs as matrix metalloprotease inhibitors in the treatment of respiratory diseases
KR1020017008314A KR20010101325A (en) 1998-12-30 1999-12-20 Use of Substituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives as Matrix Metalloprotease Inhibitors for the Treatment of Respiratory Diseases
IL14359499A IL143594A0 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
CN99816404A CN1337932A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases
EP99963582A EP1140768A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
BR9916669-0A BR9916669A (en) 1998-12-30 1999-12-20 Use of derivatives of substituted 4-biarylbutyric and 5-biarylpentanoic acids as matrix metalloprotease inhibitors for the treatment of respiratory diseases
CA002356053A CA2356053A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
ARP990106795A AR035472A1 (en) 1998-12-30 1999-12-28 USE OF 4-BIARILBUTIRIC AND 5-BIARILPENTANOIC ACID DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES, COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM
PE1999001333A PE20001339A1 (en) 1998-12-30 1999-12-28 USE OF DERIVATIVES OF 4-BIARYLBUTYRIC ACID AND 5-BIARYLPENTANOIC SUBSTITUTE AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES
CO99081622A CO5261506A1 (en) 1998-12-30 1999-12-30 USE OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES
UY25888A UY25888A1 (en) 1998-12-30 1999-12-30 DERIVATIVES OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO ACID SUBSTITUTES USEFUL AS MATRIX METALPROTEASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES
GT199900229A GT199900229A (en) 1998-12-30 1999-12-30 USE OF 4-BIARILBUTIRIC AND 5-BIARILPENTANOIC ACID DERIVATIVES SUBSTITUTED AS INHIBITORS OF THE METALOPROTEASADEMATRIZ FOR THE TREATMENT OF RESPIRATORY DISEASES.
ZA200104651A ZA200104651B (en) 1998-12-30 2001-06-07 Use of substituted 4-biarylbutyric 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases.
HK02105193.2A HK1043981A1 (en) 1998-12-30 2002-07-12 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828845.9A GB9828845D0 (en) 1998-12-30 1998-12-30 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
GB9828845D0 true GB9828845D0 (en) 1999-02-17

Family

ID=10845173

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828845.9A Ceased GB9828845D0 (en) 1998-12-30 1998-12-30 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Country Status (3)

Country Link
GB (1) GB9828845D0 (en)
GT (1) GT199900229A (en)
ZA (1) ZA200104651B (en)

Also Published As

Publication number Publication date
GT199900229A (en) 2001-06-22
ZA200104651B (en) 2002-08-28

Similar Documents

Publication Publication Date Title
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2073502A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
NO20006506D0 (en) Use of Valproic Acid Analog for the Treatment and Prevention of Migraine and Affective Diseases
HK1044536A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
HUP0104963A3 (en) Compositions for the treatment of skin diseases
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
PL356092A1 (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
GB0111594D0 (en) Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
AU2002233353A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
EP1150669A4 (en) L-arginine based formulations for treating diseases and methods of using same
GB9828845D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
GB9922709D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
HK1025894A1 (en) Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release.
EP1189584A4 (en) Alpha amino acid composition and method for the treatment of skin
AU1101301A (en) 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
AU2001273801A1 (en) Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain
AU4101900A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
HUP0301971A3 (en) Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds
AU2002316940A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)